Have a personal or library account? Click to login
Testicular function in patients with regular blood transfusion for thalassemia major Cover

Testicular function in patients with regular blood transfusion for thalassemia major

Open Access
|Jan 2017

Figures & Tables

Figure 1

The median and interquartile ranges (25th; 75th percentiles) of serum AMH levels according to the Tanner genital stage.
The median and interquartile ranges (25th; 75th percentiles) of serum AMH levels according to the Tanner genital stage.

Figure 2

The median and interquartile ranges (25th; 75th percentiles) for LH (A), FSH (B), testosterone (C), and AMH (D) according to the Tanner genital stage between thalassemia major patients (white boxes) and control group (gray boxes), ** P < 0.05.
The median and interquartile ranges (25th; 75th percentiles) for LH (A), FSH (B), testosterone (C), and AMH (D) according to the Tanner genital stage between thalassemia major patients (white boxes) and control group (gray boxes), ** P < 0.05.

The testicular volume and basal LH, FSH, testosterone and AMH levels in patients with Thalassemia major and the controls

Genital TannernAge (y)Testicular volume (mL)LH (IU/L)FSH (IU/L)Testosterone (ng/dL)AMH (pmol/L)
Tanner I
     Thalassemia1510.6 ± 1.43<0.10.95<2.5726.86
(2–4)(<0.1–0.5)(0.3–1.42)(494.29–797.86)
     Control2610.6 ± 1.4<0.10.44<2.5769.16
(0.18–1.1)(<2.5–5.6)(587.7–1,073.4)
Tanner II
     Thalassemia511.5 ± 1.051.851.8210.66340.0
(4–7)(1.1–3.4)(1.3–2.0)(6.3–26.2)(203.82–570.68)
     Control1112.5 ± 0.92.32.246.1113.17
(1.4–3.5)(1.4–2.4)(19.2–188.8)(58.33–256.10)
(P = 0.058)
Tanner III
     Thalassemia413.3 ± 0.8123.42.7139.97113.32
(12–14.3)(1.8–5.4)(1.7–3.6)(80.9–290.6)(71.48–169.47)
     Control913.7 ± 0.82.71.5196.9975.69
(2.1–4.2)(1.3–2.0)(117.0–294.1)(55.25–134.84)
Tanner IV-V
     Thalassemia414.1 ± 1.0201.94.0290.8885.71
(14–20)(1.3–2.5)(1.4–6.4)(111.5–426.6)(33.75–173.89)
     Control1815.5 ± 2.01.55.6537.484.68
(1.2–2.3)(3.5–6.6)(394.6–720.6)(45.61–137.68)
P <0.05

The demographic characteristics of patients with thalassemia major

CharacteristicMean ± SD (range)
Recent age (y)11.7 ± 1.8 (8–14.9)
Height (SDS)−0.4 ± 0.87 (−2.3–1.5)
Weight (SDS)−0.04 ± 0.87 (−1.2–2.2)
Age at diagnosis of thalassemia (y)1.9 ± 1.1 (0.4–4.4)
Onset of blood transfusion (y)3.8 ± 2.3 (0.6–9.1)
Onset of chelation therapy (y)6.6 ± 2.8 (2–12.1)
Serum ferritin level before start chelation therapy (ng/mL)1,645 ± 536 (1,019–2,846)
Mean ferritin level in 1 year (ng/mL)1,575 ± 642 (534–3,207)
Mean hemoglobin level in 1 year (g/dL)8.9 ± 0.7 (7.1–10)
Maximum ferritin level (ng/mL)3,169 ± 1,184 (1,419–6,220)
Age of maximum ferritin level (y)9.7 ± 2.4 (5.3–13.8)
DOI: https://doi.org/10.5372/1905-7415.0902.385 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 185 - 191
Published on: Jan 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Sukumarn Siripunthana, Taninee Sahakitrungruang, Suttipong Wacharasindhu, Darintr Sosothikul, Vichit Supornsilchai, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.